new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Institut National De La Sante Et De La Recherche Medicale inserm
Institut National De La Sante Et De La Recherche Medicale
Institut National De La Sante Et De La Recherche Medicale i n s e r m
Institut National De La Sante Et De La Recherche Medicale I n s e r m
Institut National De La Sante Et De La Recherche Medicale Inserm
Institut National De La Sante Et De La Recherche Medicale inserm_20100121
Institut National De La Sante Et De La Recherche Medicale_20100114
Institut National De La Sante Et De La Recherche Medicale inserm fr fr
  

Institut National De La Sante Et De La Recherche Medicale patents

Recent patent applications related to Institut National De La Sante Et De La Recherche Medicale. Institut National De La Sante Et De La Recherche Medicale is listed as an Agent/Assignee. Note: Institut National De La Sante Et De La Recherche Medicale may have other listings under different names/spellings. We're not affiliated with Institut National De La Sante Et De La Recherche Medicale, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Institut National De La Sante Et De La Recherche Medicale-related inventors




Date Institut National De La Sante Et De La Recherche Medicale patents (updated weekly) - BOOKMARK this page
04/06/17Methods of generating corneal cells and cell populations comprising same
02/16/17Compositions having means for targeting at least one antigen to dendritic cells
02/09/17Treatment of myotonic dystrophy
01/19/17Piperazine phenothiazine derivatives for treating spasticity
01/05/17New target for diabetes treatment and prevention
09/15/16Dynamin 2 inhibitor for the treatment of centronuclear myopathies
08/25/16Methods for predicting the progression and treating a chronic kidney disease in a patient
07/28/16Method for in vitro quantifying allo-antibodies, auto-antibodies and/or therapeutic antibodies
07/21/16Agents for the molecular imaging of serine-protease in human pathologies
06/16/16Use of hepcidin as a regulator of iron homeostasis
05/19/16Immunogenic composition in emulsion form comprising two dispersed phases, one comprising an antigen and the other comprising an immunostimulating agent
05/12/16Kir3dl2 is a biomarker and a therapeutic target useful for respectively preventing and treating a subset of cutaneous and non-cutaneous peripheral t-cell lymphomas
05/05/16Methods for predicting rheumatoid arthritis treatment response
03/17/16Composition with reduced immunogenicity
12/17/15Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (mv-deltac virus) in cancer therapy
12/03/15Intracellular phenotypic screening
10/15/15Glycoconjugates and their use as potential vaccines against infection by shigella flexneri
09/24/15Methods for the treatment of tinnitus induced by cochlear excitotoxicity
08/27/15Eye injection device
07/09/15Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
04/30/15Method for characterising the physiological state of a patient from the analysis of the cerebral electrical activity of said patient, and monitoring device applying said method
04/30/15Method for characterising the physiological state of a patient from the analysis of the cerebral electrical activity of said patient, and monitoring device applying said method
04/23/15Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
03/12/15Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (ibd) and irritable bowel syndrome (ibs)
02/26/15Monoclonal antibodies that bind b7h6 and uses thereof
02/26/15Methods for the treatment of tinnitus induced by cochlear excitotoxicity
02/19/15Use of a glycosylated-modified tetrafunctional non-ionic amphiphilic block copolymer as immune adjuvant
02/12/15Universal carrier for targeting molecules to gb3 receptor expressing cells
01/08/15Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
08/14/14Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof
07/17/14Compositions having means for targeting at least one antigen to dendritic cells
02/13/14Nanocapsulation of essential oils for preventing or curing infectious diseases alone or with an antibiotic
12/05/13Spinal muscular atrophy diagnostic methods
11/28/13Combination of biomarkers for the prognosis of response or non-response to an anti-hcv treatment
06/23/11Eye injection device
06/09/11Use of l-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vitro
02/03/11Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis
11/18/10Use of il-18 inhibitors for treatment and/or prevention of peripheral vascular diseases
04/22/10Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
03/18/10Phosphohalohydrins, process for the production thereof and use thereof
01/14/10Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use
12/10/09Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta t cell activators
11/12/09Method for determining the molecular composition of a target tissue or another body structure, and its diagnostic applications
10/01/09Derivatives of epirubicin, their medicinal application and pharmaceuticaly acceptable forms of drugs
09/24/09Il-15ralpha sushi domain as a selective and potent enhancer of il-15 action through il-15beta/gamma, and hyperagonist (il-15ralpha sushi - il-15) fusion proteins
09/03/09Cb2 receptors blocks accumulation of human hepatic myofibroblasts: a novel antifibrogenic pathway in the liver
08/27/09Disease-associated proteins
08/13/09Modified phosphocalcic compound, injectable composition containing same
07/30/09Antibody or a fragment thereof, having neutralizing activity against hiv
04/09/09Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis
01/14/10Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use
04/27/17 new patent  Anti-cd28 humanized antibodies
04/20/17Influenza vaccine, composition, and methods of use
03/16/17Pooled nk cells from ombilical cord blood and their uses for the treatment of cancer and chronic infectious disease
03/16/17Detection of shed cd31, diagnosis of atherothrombosis and autoimmune disorders, and methods for analyzing signaling pathways
03/09/17Detection of platelet-derived shed cd31
03/02/17Fkbp52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
02/23/17Method and device for conserving viable and functional human polymorphonuclear neutrophils
02/09/17New lipophenol compounds and uses thereof
02/02/17Use of cranberry proanthocyanidin for treatment of oropharyngeal bacterial colonization
01/05/17Use of a neurofilament peptide for the treatment of glioma
01/05/17Cd300a receptors as virus entry cofactors
12/22/16Shear wave imaging method and installation for collecting information on a soft solid
12/22/16Methods and compositions for the treatment of beta-thalassemia
12/15/16Treatment of cardiac diseases with modulators of the hippo pathway
Patent Packs
12/15/16Bioactive modification of poly(vinyl alcohol) with surface topography and biochemical cues for vascular graft
12/01/16Method for increasing the intraocular pressure in an animal
12/01/16Diagnosis of hereditary spastic paraplegias (hsp) by detection of a mutation in the kiaa1840 gene or protein
11/24/16Bacterial influence of host feeding and emotion via clpb protein mimicry of a-msh
11/24/16Method for measuring a biological value of a liver
11/17/16Water soluble 4-azapodophyllotoxin analogs
11/10/16Aptamers inhibiting the enzymatic activity of the mmp-9 protein
11/03/16Tet2 as a diagnostic and pronostic marker in hematopoietic neoplasms
10/27/16Method for post-processing magnetic resonance imaging images in a clinical context
10/27/16Bacterial influence on regulation of appetite via clpb protein mimicry of alpha-msh
10/06/16Method for in vitro diagnosing and prognosing of triple negative breast cancer recurrence
09/22/16Adjustable speed fast laser scanning system and two-photon microscope associated
09/08/16Invention
09/01/16New methods to produce active tert
08/25/16Puma protein expression vector and use thereof in gene therapy
Patent Packs
08/25/16New pi3k/akt/mtor inhibitors and pharmaceutical uses thereof
08/18/16Rny-derived small rnas as biomarkers for atherosclerosis-related disorders
07/07/16Anticonvulsive pharmaceutical compositions
07/07/16Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins
07/07/16Novel mutated tissue plasminogen activators and uses thereof
07/07/16Correlation of disease activity with clonal expansions of human papillomavirus 16-specific cd8+ t-cells in patients with severe erosive oral lichen planus
06/30/16Vaccines for preventing meningococcal infections
06/09/16Inhibition of the synthesis of beta-app or of the activity of the a-beta peptide in the choroid plexus
06/02/16Method for imaging a medium through electrical measurements with a contact impedance correction
05/19/16Three-dimensional scaffold functionalized with micro-tissues for tissue regeneration
05/19/16Shear wave imaging method and installation for collecting information on a soft solid
05/12/16Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof
04/28/16Hydrophobically modified antisense oligonucleotides comprising a triple alkyl chain
04/21/16Cgrp receptor agonist for hiv treatment or prevention
04/21/16Hydrophobically modified antisense oligonucleotides comprising a ketal group
03/24/16Methods and compositions for stimulating reepithelialisation during wound healing
03/24/16Anti-ghrelin antibodies and uses thereof
03/10/16Non human animal model for ulcerative colitis and its main complications
02/25/16Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3
02/25/16Methods for predicting cardiovascular mortality risk
02/18/16Attenuated bordetella strains
02/18/16Methods to obtain a novel class of gram negative bacteria antibiotics which target an unknown cell division associated protein lop1
02/18/16Method for monitoring cancer and/or inflammatory reaction based on relb phosphorylation
02/18/16Fkbp52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
02/11/16Particles containing a growth factor, and uses thereof
02/04/16Compositions for preventing and/or treating an infection by an hiv-1 virus
01/21/16Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
01/21/16Tam receptors as virus entry cofactors
01/21/16Tim receptors as virus entry cofactors
01/21/16Marker of breast tumors from the luminal-b subtype
Social Network Patent Pack
01/07/16Method for classifying an inflammatory bowel disease as a crohn's disease or as an ulcerative colitis
12/31/15Cell-free translation system
12/31/15Dominant negative hsp110 mutant and its use in prognosing and treating cancers
12/24/15Diagnostic and treatment of chronic heart failure
12/24/15Methods for predicting the survival time of a patient suffering from a solid cancer
12/03/15Diagnosis of cystic fibrosis
11/19/15Porous polysaccharide scaffold comprising nano-hydroxyapatite and use for bone formation
11/19/15Method for preparing c1q recombinant protein
11/19/15Aptamers inhibiting the enzymatic activity of tyrosinase
11/05/15Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to friedreich ataxia
Patent Packs
10/29/15Flt3 receptor antagonists for the treatment or the prevention of pain disorders
10/29/15Method and system for processing data for evaluating a quality level of a dataset
10/22/15Method for classification of liver samples and diagnosis of focal nodule dysplasia, hepatocellular adenoma, and hepatocellular carcinoma
10/15/15Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response
10/15/15Recombinant mycobacterium encoding a heparin-binding hemagglutinin (hbha) fusion protein and uses thereof
10/15/15Methods for cancer management targeting co-029
10/15/15Method for diagnosing a hemoglobin-related disorder
09/24/15Method for renal transplantation
09/24/15In vitro the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
09/10/15Lkb1 as predictive marker of everolimus efficacy in breast cancer
09/10/15Peptide antagonists of the vasopressin-2 receptor
09/03/15Compounds and methods for preventing or treating a viral infection
08/20/15Method for prognosis of global survival and survival without relapse in hepatocellular carcinoma
08/13/15Importation of mitochodrial protein by an enhanced allotopic approach
08/06/15Nucleic acids targeting tctp for use in the treatment of chemo-or hormone- resistant cancers
07/30/15Novel recombinant bordetella strains
07/30/15Detection of the eralpha/src/pi3k complex as predictive marker in breast cancer
07/23/15Method of using attenuated bordetella strains
07/23/15Cd31 peptides
07/23/15Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of mgus or myeloma patients
07/16/15Cultured myeloid dendritic cells isolated from peyers patches and uses thereof
07/09/15Combination products for treating cancer
07/09/15Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies
07/02/15Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
06/25/15Method of hepatocellular carninoma classification and prognosis
06/18/15Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome
05/21/15Radioactive rhodium complexes, preparation methods and uses thereof
05/21/15Methods and compositions for the treatment of beta-thalassemia
04/23/15Method for in vitro differentiation of blood circulating cells into neuronal-like cells and applications thereof
04/16/15Methods and kits for predicting the risk of having a cardiovascular event in a subject
Patent Packs
04/16/15Method for manufacturing cubic diamond nanocrystals
04/09/15Sodium thiosulphate for the treatment of ectopic calcifications
04/02/15Use of neuroglobin agonist for preventing or treating mitochondrial rcci and/or rcciii deficiency disease
03/26/15Importation of mitochodrial protein by an enhanced allotopic approach
03/19/15Methods of growing an embryo to a blastocyst stage of development
03/12/15Anti-cd28 humanized antibodies
03/05/15Detection of platelet-derived shed cd31
02/19/15Novel mutated tissue plasminogen activators and uses thereof
02/19/15Identification of a jak2 mutation in polycythemia vera
02/12/15Correlation of disease activity with clonal expansions of human papillomavirus 16-specific cd8+ t-cells in patients with severe erosive oral lichen planus
02/05/15Methods and pharmaceutical compositions for the treatment of th2 mediated diseases
01/29/15Mutations of the gpr179 gene in congenital stationary night blindness
01/22/15Number of il4 and/or il13 secreting t-cells as a biomarker for allergic diseases
01/15/15Biomarkers of renal disorders
01/08/15Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3
01/01/15Population of immunoregulatory t cells specific for an irrelevant antigen and uses thereof for preventing or treating immune diseases
01/01/15Vaccine compositions for hiv prevention and treatment
12/25/14Method for prognosing the age-at-onset of huntington's disease
12/25/14Importation of mitochodrial protein by an enhanced allotopic approach
12/18/14Method for predicting responsiveness to a treatment with an egfr inhibitor
Social Network Patent Pack
12/18/14Non human animal model for ulcerative colitis and its main complications
11/06/14Nutlin compounds for use in the treatment of pulmonary hypertension
10/23/14Device for the treatment of an ocular disease
10/23/14Device for the treatment of an ocular disease
10/16/14Diagnosis of hereditary spastic paraplegias (hsp) by detection of a mutation in the kiaa1840 gene or protein
10/16/14Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject
09/25/14Methods, pharmaceutical compositions and kits for use in the treatment of adult t-cell leukemia/lymphoma
09/18/14Effect of an attenuated bordetella strain against allergic disease
09/04/14Methods and kits for detecting cardiac remodeling in subjects without clinical signs of heart failure
08/21/14Small efficient cell penetrating peptides derived from the scorpion toxin maurocalcine
07/31/14Novel mutated tissue plasminogen activators and uses thereof
07/24/14Promyelocytic leukemia protein as a redox sensor
07/24/14Methods and pharmaceutical compositions for the treatment of respiratory tract infections
07/17/14Inhibitors of cathepsin s for prevention or treatment of obesity-associated disorders
07/03/14Method for predicting insulinopenic type 2 diabetes
07/03/14Non human animal models for increased retinal vascular permeability
06/26/14Method for increasing the intraocular pressure in an animal
06/26/14New inhibitors of cyclophilins and uses thereof
06/12/14Fkbp52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
06/05/14Recombinant vector for producing and secreting peptide or protein of interest by propionibacteria and applications thereof
Social Network Patent Pack
05/08/14Mutant cytochrome p450 2b6 proteins and uses thereof
05/08/14Curcuminoids in combination docetaxel for the treatment of cancer and tumour metastasis
05/01/14Therapeutic peptides and use thereof against huntington's disease
03/27/14Methods and pharmaceutical compositions for the treatment of autoimmune diseases
03/27/14Use of blood or tissue bacteriome for prediction, diagnosis and prevention of metabolic diseases and their cardiovascular complications
03/27/14Method for predicting abdominal obesity
03/13/14Method of treating rheumatoid arthritis
02/20/14Methods for preparing accessory cells and uses thereof for preparing activated nk cells
02/06/14Culture medium and obtaining a population of tolerogenic dendritic cells
01/23/14Method for the prognosis of progression of the hiv disease
01/02/14Aminoalkylsterol compounds with antitumoral and neuroprotective activity
12/05/13C-glucosidic ellagitannin compounds for use for altering the supramolecular arrangement of actin and for the treatment of osteoporosis, cancer, bacterial infection and viral infection
11/28/13Method for evaluating the vital prognosis of a subject in a critical condition
11/21/13Diagnosis of asymptomatic left ventricular systolic dysfunction
11/21/13Method and kits for determining platelet susceptibility to activation in a patient
10/03/13Serene protease derivatives and uses in the prevention or the treatment of blood coagulation disorders
10/03/13Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject
08/29/13Method for the prognosis of the progression of cancer
08/29/13Porous polysaccharide scaffold comprising nano-hydroxyapatite and use for bone formation
08/22/13Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
07/25/13Identification of a jak2 mutation involved in vaquez polyglobulia
07/04/13Tool for inserting fine tubular objects into the cochlea
06/20/13Methods for the treatment and the diagnosis of cancer
06/13/13Treatment of a disease associated with retinal degenerative disorder
06/06/13Method for classifying an inflammatory bowel disease as a crohn's disease or as an ulcerative colitis
06/06/13Methods and compositions for stimulating reepithelialisation during wound healing
05/02/13Recombinant vector for producing and secreting amino acid sequences of interest by propionibacteria and applications thereof
12/20/12Composition for the treatment of atherosclerosis
10/11/12Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
09/27/12Dendritic cells (dcs) targeting for tuberculosis (tb) vaccine
Social Network Patent Pack
03/08/12Novel multimodular assembly useful for intracellular delivery
02/16/12Method for demonstration of a molecular event in a cell by means of fluorescent marker proteins
02/16/12Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen
02/02/12Use of anti-cd100 antibodies
12/22/11Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumor cells
12/22/11Method of prognosis and/or diagnosing an irs in a patient infected with m. tuberculosis and optionally hiv
12/22/11Dna and proteins or peptides specific of bacteria of the neisseria meningitidis species, methods for obtaining them and biological applications thereof
11/10/11Aminoalkylsterol compounds with antitumoral and neuroprotective activity
10/27/11Vaccine against infectious agents having an intracellular phase, composition for the treatment and prevention of hiv infections, antibodies and methods of diagnosis
10/27/11Tet2 as a new diagnostic and pronostic marker in hematopoietic neoplasms
10/27/11Use of xanthone derivatives as a medicament for cancer
07/28/11Anti-glycoptrotein vi scfv fragment for treatment of thrombosis
07/28/11Methods for modulating angiogenesis via dystrophin dp71
07/21/11Use of sco-spondin peptides for inhibiting or preventing neuronal apoptosis mediated by cell death receptor ligands
07/07/11Lsr receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
06/09/11Compounds having a potentiating effect on the activity of ethionamide and uses thereof
06/02/11Use of serine protease inhibitors in the treatment of skin diseases
02/17/11Molecular classifier for prognosis in multiple myeloma
02/10/11Use of the cyp46a1 gene for the treatment of alzheimer's disease
01/13/11Muscle-derived cells having differentiation capacities
12/02/10Non-conventional nkt cells for use in cancer therapy
11/25/10Aqueous-core lipid nanocapsules for encapsulating hydrophilic and/or lipophilic molecules
09/16/10Identification of new isoforms of the mhc-class i specific receptor cd160 and uses thereof
09/02/10Combination products for treating cancer
08/19/10Polymorphic length of foxe1 alanine stretch and genetic susceptibility to thyroid dysgenesis
08/12/10Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
08/05/10Foodstuff composition to improve digestibility of foodstuff lipids
08/05/10Demannosylated recombinant factor viii [[vii]] for the treatment of patients with haemophilia a
07/15/10Pharmaceutical composition which improves in vivo gene transfer







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Institut National De La Sante Et De La Recherche Medicale in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Institut National De La Sante Et De La Recherche Medicale with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';